在设备检测到的AF中,DOAC与阿司匹林或安慰剂相比可以减少缺血性中风并增加主要出血
1University of Michigan Frankel Cardiovascular Center, Ann Arbor, Michigan, USA (G.D.B.).
Annals of internal medicine
|July 1, 2024
概括
直接口服抗凝剂没有降低设备检测到心房的患者中风风险. 这一对NOAH-AFNET 6和ARTESiA试验的元分析为临床实践提供了关键的见解.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 临床试验 临床试验
背景情况:
- 心房动是一种常见的心律失常,与中风风险增加有关.
- 设备检测到的心房动 (DDAF) 在中风预防管理中提出了独特的挑战.
- 目前的指导方针在DDFDAF中提供了有限的抗凝血建议.
研究的目的:
- 评估直接口服抗凝剂 (DOAC) 在患有DDAF的患者中风预防方面的疗效.
- 对NOAH-AFNET 6和ARTESiA试验进行研究水平的元分析.
- 为在DDAF群体中关于抗凝血的临床决策提供信息.
主要方法:
- 研究水平的元分析,结合了来自NOAH-AFNET 6和ARTESiA试验的个体患者数据.
- 包括被诊断患有DDAF的患者.
- 评估中风和全身血栓塞作为主要结局.
主要成果:
- 与安慰剂相比,在患有DDAF的患者中,DOACs并没有显著降低中风或全身栓塞的风险.
- 通过DOACs观察到,中风,全身血栓塞或心血管原因死亡的复合结果没有显著减少.
- 在DOAC组中,出血事件更频繁,与已知的安全概况一致.
结论:
- 在患有DDAF的患者中,DOAC不能有效预防中风.
- 这些发现挑战了在这种特定患者群体中对DOACs的常规使用.
- 需要进行进一步的研究,以确定在DDAF中对中风风险管理的最佳策略.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
517
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
517
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
01:17Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K